Here, myeloid-FATP4 deficiency may promote male-prone abnormalities by exacerbating hepatic steatosis possibly via the strong activation of PPARγ, CEBPα, and p-FoxO1 in their Kupffer cells (Fig. 3F). This evidence concerns the gene PPARG and fatty liver disease.